Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Van Laar

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulationR Hilker, A T Portman, J Voges, et al.
BMC Neurology|November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-studyConstant V M Verschuur, S R Suwijn, B Post, et al.
Oncogene|September 18, 2007
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alphaE H Gort, G van Haaften, I Verlaan, et al.
BMC Neurology|July 19, 2019
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's diseaseB R Bloem, W J Marks, A L Silva de Lima, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulationR Hilker, A T Portman, J Voges, et al.
BMC Neurology|November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-studyConstant V M Verschuur, S R Suwijn, B Post, et al.
Oncogene|September 18, 2007
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alphaE H Gort, G van Haaften, I Verlaan, et al.
BMC Neurology|July 19, 2019
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's diseaseB R Bloem, W J Marks, A L Silva de Lima, et al.
Pageof 7